NCT00349882

Brief Summary

The purpose of this study is to compare the performance of two different contact lens care solutions, specifically their affects on the front surface of the eye.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2005

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

July 5, 2006

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 10, 2006

Completed
Last Updated

July 10, 2006

Status Verified

July 1, 2006

First QC Date

July 5, 2006

Last Update Submit

July 5, 2006

Conditions

Outcome Measures

Primary Outcomes (2)

  • The primary outcome measure of this study is to investigate the effects of two

  • different contact lens care solutions on the cornea.

Secondary Outcomes (2)

  • The secondary outcome measure of this study is to compare the subjective and

  • objective responses between two different contact lens care solutions.

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Is at least 18 years old and has full legal capacity to volunteer.
  • Has read, understood and signed an Information Consent Letter.
  • Is willing and able to follow instructions and maintain the appointment schedule.
  • Is correctable to a visual acuity of 6/6 or better (each eye), with their habitual visual correction.
  • Has normal binocular vision (no strabismus, no amblyopia, and anisometropia less than or equal to 1.00 D).
  • Has clear corneas and no active ocular disease.
  • Has had an ocular examination in the last 2 years.
  • Has not worn contact lenses before, or has worn contact lenses only for a trial period, with no trials occurring within the last six months.
  • An ineligible contact lens wearer is one who:
  • Responds positively to points 1 to 7 above.
  • Has a distance contact lens prescription between -0.50D and -9.00 D.
  • Has astigmatism less than or equal to -1.00D cyl.
  • Currently wears silicone hydrogel contact lenses successfully.
  • Agrees to wear the study lenses on a daily wear basis without the use of ocular or lens lubricants.

You may not qualify if:

  • Has undergone corneal refractive surgery.
  • Is aphakic.
  • Has any active ocular disease.
  • Has any systemic disease affecting ocular health.
  • Is using any systemic or topical medications that may affect ocular health.
  • Has known sensitivity to the diagnostic pharmaceuticals to be used in the study.
  • Is pregnant or lactating.
  • Is participating in any other type of clinical or research study.
  • An ineligible contact lens wearer is one who:
  • Has known sensitivity to the contact lens care solutions used in the study.
  • Has ocular or systemic allergies that could adversely affect contact lens wear.
  • Has any ocular pathology or severe insufficiency of lacrimal secretion (dry eyes) that would affect the wearing of contact lenses.
  • Has pinguecula/pterygium that in the investigator's judgement makes contact lens wear inadvisable.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre for Contact Lens Research, University of Waterloo

Waterloo, Ontario, N2L 3G1, Canada

Location

MeSH Terms

Conditions

Myopia

Interventions

Contact Lenses, Hydrophilic

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Intervention Hierarchy (Ancestors)

Contact LensesLensesOptical DevicesEquipment and Supplies

Study Officials

  • Craig Woods, PhD

    University of Waterloo

    PRINCIPAL INVESTIGATOR
  • Desmond Fonn, MOptom

    University of Waterloo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 5, 2006

First Posted

July 10, 2006

Study Start

June 1, 2005

Last Updated

July 10, 2006

Record last verified: 2006-07

Locations